View Single Post
Old 09-03-2013, 11:55 PM
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
johnt johnt is offline
Senior Member
 
Join Date: Apr 2009
Location: Stafford, UK
Posts: 1,059
15 yr Member
Default

Thanks for posting the link.

In my opinion, alpha-synuclein's key role in the etiology of PD is as good as proven, although the details remain:
- what causes the misfolding to start?
- when does an instance of misfolding become prion-like and "reproduce"?
- is a genetic predisposition to over express AS important?
- are rogue forms of AS communicable?

Clumping seems bad news, but in vitro tests [1] have shown that curcumin can reduce aggregation.

Tag johnt:alpha-synuclein

Reference:

[1] J Biol Chem. 2012 Mar 16;287(12):9193-9. doi: 10.1074/jbc.M111.325548. Epub 2012 Jan 20.
"Curcumin prevents aggregation in α-synuclein by increasing reconfiguration rate."
Ahmad B, Lapidus LJ.
http://www.ncbi.nlm.nih.gov/pubmed/22267729

John
__________________
Born 1955. Diagnosed PD 2005.
Meds 2010-Nov 2016: Stalevo(75 mg) x 4, ropinirole xl 16 mg, rasagiline 1 mg
Current meds: Stalevo(75 mg) x 5, ropinirole xl 8 mg, rasagiline 1 mg

Last edited by johnt; 09-04-2013 at 01:31 AM. Reason: Spelling
johnt is offline   Reply With QuoteReply With Quote